Home » Topics » BioWorld Science

BioWorld Science
RSS

Lidakol clinical trial update

March 15, 1996

Antiviral drugs from Glaxo Wellcome

March 15, 1996

Human lactoferrin produced in transgenic animals

March 15, 1996

UR-9751 dropped from development

March 15, 1996

Antipsoriatic treatment in development at Immune Response

March 15, 1996

Human Genome Sciences claims novel wound-healing agents

March 15, 1996

Zeneca acquires antimigraine drug

March 15, 1996

Abbott and Purdue Pharma to copromote analgesic

March 15, 1996

Hoechst Marion Roussel claims new analgesics

March 13, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...